CTS-1027

CTS-1027

CAT N°: 33219
Price:

From 111.00 94.35

CTS-1027 is an inhibitor of matrix metalloproteinases (MMPs).{67181} It is selective for MMP-2, MMP-9, and MMP-13 (Kis= 0.22, 0.55, and 0.52 nM, respectively) over MMP-3 and MMP-1 (Kis= 9.3 and 590 nM, respectively). CTS-1027 (10 mg/kg) reduces hepatocyte apoptosis and bile infarcts and increases survival in a mouse model of bile duct ligation-induced cholestatic liver injury.{67180}

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • 4-[[[4-(4-chlorophenoxy)phenyl]sulfonyl]methyl]tetrahydro-N-hydroxy-2H-pyran-4-carboxamide
  • Correlated keywords
    • 1200173-22-3 CTS1027 1130830 Ro1130830 Ro113 RS130830 MMP2 MMP9 MMP13 MMP3 MMP1
  • Product Overview:
    CTS-1027 is an inhibitor of matrix metalloproteinases (MMPs).{67181} It is selective for MMP-2, MMP-9, and MMP-13 (Kis= 0.22, 0.55, and 0.52 nM, respectively) over MMP-3 and MMP-1 (Kis= 9.3 and 590 nM, respectively). CTS-1027 (10 mg/kg) reduces hepatocyte apoptosis and bile infarcts and increases survival in a mouse model of bile duct ligation-induced cholestatic liver injury.{67180}

We also advise you